NASDAQ:FENC Adherex Technologies (FENC) Stock Price, News & Analysis $11.72 -0.34 (-2.82%) Closing price 08/14/2026 04:00 PM EasternExtended Trading$11.72 0.00 (0.00%) As of 08/14/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock About Adherex Technologies Stock (NASDAQ:FENC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Adherex Technologies alerts:Sign Up Key Stats Today's Range$11.70▼$12.2550-Day Range$8.70▼$12.7852-Week Range$5.65▼$13.25Volume106,940 shsAverage Volume183,730 shsMarket Capitalization$410.90 millionP/E RatioN/ADividend YieldN/APrice Target$16.40Consensus RatingModerate Buy Company Overview Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina. Read More Adherex Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks78th Percentile Overall ScoreFENC MarketRank™: Adherex Technologies scored higher than 78% of companies evaluated by MarketBeat, and ranked 148th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingAdherex Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialAdherex Technologies has a consensus price target of $16.40, representing about 39.9% upside from its current price of $11.72.Amount of Analyst CoverageAdherex Technologies has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Adherex Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth237.93% Earnings GrowthEarnings for Adherex Technologies are expected to grow by 237.93% in the coming year, from $0.29 to $0.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Adherex Technologies is -90.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Adherex Technologies is -90.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAdherex Technologies has a P/B Ratio of 11.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.97% of the float of Adherex Technologies has been sold short.Short Interest Ratio / Days to CoverAdherex Technologies has a short interest ratio ("days to cover") of 5.32.Change versus previous monthShort interest in Adherex Technologies has recently increased by 1.10%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdherex Technologies does not currently pay a dividend.Dividend GrowthAdherex Technologies does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.67 News SentimentAdherex Technologies has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Adherex Technologies this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added Adherex Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Adherex Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders10.73% of the stock of Adherex Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.51% of the stock of Adherex Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Adherex Technologies' insider trading history. Receive FENC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adherex Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FENC Stock News HeadlinesAdherex Technologies (NASDAQ:FENC) Earns Buy Rating from B. Riley FinancialAugust 14 at 2:24 AM | americanbankingnews.comAdherex Technologies (NASDAQ:FENC) Stock Price Expected to Rise, Wedbush Analyst SaysAugust 14 at 2:24 AM | americanbankingnews.comPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. | Porter & Company (Ad)Adherex Technologies (FENC) Projected to Post Quarterly Earnings on ThursdayAugust 6, 2026 | americanbankingnews.comFennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026August 5, 2026 | globenewswire.comAdherex Technologies Inc. (NASDAQ:FENC) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAugust 4, 2026 | americanbankingnews.comFennec Announces Results of Annual MeetingJune 10, 2026 | globenewswire.comAdherex Technologies' PEDMARK push targets larger AYA market after record quarterMay 23, 2026 | msn.comSee More Headlines FENC Stock Analysis - Frequently Asked Questions How have FENC shares performed this year? Adherex Technologies' stock was trading at $7.70 at the beginning of the year. Since then, FENC stock has increased by 52.2% and is now trading at $11.72. How were Adherex Technologies' earnings last quarter? Adherex Technologies Inc. (NASDAQ:FENC) posted its quarterly earnings data on Thursday, August, 13th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. The company had revenue of $17.87 million for the quarter, compared to the consensus estimate of $16.21 million. Adherex Technologies had a negative net margin of 6.09% and a negative trailing twelve-month return on equity of 6.93%. Read the conference call transcript. How do I buy shares of Adherex Technologies? Shares of FENC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Adherex Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Adherex Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG). Company Calendar Last Earnings8/13/2026Today8/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 FENC's financial health is in the Green zone, according to TradeSmith. FENC has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:FENC CIK1211583 Webwww.fennecpharma.com Phone919-636-4530Fax919-890-0490Employees10Year Founded1996Price Target and Rating Average Price Target for Adherex Technologies$16.40 High Price Target$18.00 Low Price Target$14.00 Potential Upside/Downside+39.9%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.13) Trailing P/E RatioN/A Forward P/E Ratio40.41 P/E GrowthN/ANet Income-$9.74 million Net Margins-6.09% Pretax Margin-16.21% Return on Equity-6.93% Return on Assets-2.48% Debt Debt-to-Equity RatioN/A Current Ratio6.98 Quick Ratio6.78 Sales & Book Value Annual Sales$44.64 million Price / Sales9.20 Cash FlowN/A Price / Cash FlowN/A Book Value$1.04 per share Price / Book11.27Miscellaneous Outstanding Shares35,060,000Free Float31,296,000Market Cap$410.90 million OptionableOptionable Beta1.09 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:FENC) was last updated on 8/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FENC Stock Alerts